Advances in Percutaneous Ventricular Assist Devices


The latest in pVAD hemodynamic support technology in development and a look at future devices to treat heart failure.

Start-up company Procyrion Inc. is developing a catheter-deployed pVAD intended for long-term use in the treatment of chronic heart failure (HF). The company said its 6 mm diameter Aortix™ device can be delivered via a catheter in a minimally invasive outpatient procedure lasting about 10 minutes.

Read More